hcc: nivolumab's side effects
Published 6 years ago • 5.2K plays • Length 4:51Download video MP4
Download video MP3
Similar videos
-
1:10
dr. welling on the efficacy of nivolumab in hcc
-
5:57
considerations for using nivolumab in advanced hcc
-
5:41
second-line nivolumab in liver cancer
-
1:00
prime-hcc: ipilimumab and nivolumab in liver cancer
-
2:18
dr. welling on checkmate-040 trial of nivolumab in hcc
-
1:15
dr. sangro discusses safety profile of nivolumab in hcc
-
5:20
nivolumab and checkpoint inhibitors in hcc
-
1:09
dr. sangro on the efficacy of nivolumab in hcc
-
2:18
use of immunotherapy for hcc
-
3:21
hepatocellular carcinoma: recent approval of nivolumab
-
1:05:05
hcc: optimizing outcomes with new and emerging treatment approaches
-
6:02
hcc: considerations in first-line use of sorafenib
-
7:14
proactive management of tki side effects in hcc
-
1:51
managing side effects with regorafenib in hcc
-
55:23
hepatocellular carcinoma: a guide to integrating emerging therapies into current treatment paradigms
-
2:53
a patient with hepatocellular carcinoma (hcc) treated with nivolumab (opdivo) post sorafenib
-
1:26:24
hepatocellular carcinoma: expert insights from the patient casebook
-
1:35:10
mapping the optimal treatment route in hcc: best practices
-
58:25
molecular targeted therapies for advanced hcc